Public Alert No. 28/2021 – Alert on Recall of Chantix (Varenicline) Tablets by Pfizer, Due to the Presence of Nitrosamine, N-Nitroso-Varenicline above Pfizer Established Acceptable Daily Intake (ADI) Level.
, The National Agency for Food and Drug Administration and Control (NAFDAC) has received information from US FDA that Pfizer is voluntarily recalling twelve (12) lots of Chantix (Verencline) Tablets – two 0.5 mg tablet lots, two 1.0 mg tablet lots, and eight lots of a Chantix kit that includes both 0.5 mg and 1.0 […]
Public Alert No.027/2021- Statins: Drug Safety Communication – US Food And Drug Administration (FDA) Requests Removal Of Strongest Warning Against Using Cholesterol-Lowering Statins During Pregnancy
, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed by the U.S FDA about revisions to the prescribing information of the entire class of statin medicines, regarding their use in pregnancy. These changes include removing the contraindication against using these medicines in all pregnant patients. A contraindication is FDA’s […]
DG’s Flag-off of the Agency’s Sensitization Campaigns
, ADDRESS BY DIRECTOR-GENERAL OF NAFDAC, PROF. MOJI CHRISTIANAH ADEYEYE AT THE FLAG-OFF OF THE AGENCY’S SENSITIZATION CAMPAIGNS ON WEDNESDAY 4TH AUGUST,2021 IN ABUJA. PROTOCOLS It is indeed a great pleasure for me to welcome you all to this very important and significant sensitization campaign scheduled to hold in Eight States of the Federation. The […]
Public Alert No. 026/2021 – Alert On Recall Of Imperia Elita Vitaccino Coffee By Dash Xclusive Due To The Presence Of Undeclared Sibutramine And Fluoxetine
, The National Agency for Food and Drug Administration and Control (NAFDAC) has received information from US FDA that Dash Xclusive is voluntarily recalling all lots of Imperia Elita Vitaccino Coffee. This was due to FDA’s result of analysis which has shown the product contains undeclared sibutramine and fluoxetine. Sibutramine was an FDA-approved drug used […]
Public Alert No. 025/2021- Alert on Recall of Poseidon Platinum 3500 by Yamtun7 Due to the Presence of Undeclared Tadalafil and Sildenafil
, The National Agency for Food and Drug Administration and Control has been informed by the U.S. Food and Drug Administration that Yamtun7 is voluntarily recalling all lots of Poseidon Platinum 3500. The result of analysis by FDA found the product to contain undeclared tadalafil and sildenafil. Tadalafil and sildenafil are drugs known as phosphodiesterase […]
NAFDAC Recommends The Following Vaccines For Emergency Use Authorization
, Moderna (Rovi Pharma Madrid, Spain) AstraZeneca AZD1222 Sputnik V (Gamaleya National Centre of Epidemiology and Microbiology, Russia) INTRODUCTION NAFDAC is announcing the approval of Moderna and AstraZeneca vaccines and conditional approval of Sputnik V vaccine. The NAFDAC Vaccine Committee has been carefully assessing several vaccines despite the fact the vaccines have been approved by […]
Public Alert No.024/2021 – Boston Scientific Corporation Recalls VICI VENOUS STENT System and VICI RDS VENOUS STENT System for Potential of Stent Migration
, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed by the U.S Food and Drug Administration (FDA) that Boston Scientific is recalling the VICI VENOUS STENT System (VICI SDS) and RDS VENOUS STENT Systems after reports indicate that the stents may migrate or move from where they are initially […]
Public Alert No.023/2021 – Miracle8989 Issues Voluntary Nationwide Recall of PremierZen Gold 7000, PremierZen Platinum 8000 and MaxxZEN Platinum 12000, Due to Presence of Undeclared Sildenafil and Tadalafil
, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed by the U.S Food and Drug Administration that Irving, Texas, Miracle8989 is voluntarily recalling all lots of PremierZen Gold 7000, PremierZen Platinum 8000 and MaxxZEN Platinum 12000, capsules to the consumer level. FDA analysis has found the products to contain […]
Public Alert No.022/2021 – Update: FDA Recommends Transition from Use of Non-NIOSH-Approved and Decontaminated Disposable Respirators – Letter to Health Care Personnel and Facilities
, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed that the U.S. Food and Drug Administration (FDA) is recommending health care personnel and facilities to transition away from crisis capacity conservation strategies, such as using non-NIOSH-approved disposable respirators, including non-NIOSH-approved imported respirators such as KN95s. This recommendation is in […]
Public Alert No: 021/2021 – Illegal Distribution And Sale Of Unregistered Brands Of Milky Creamer Products In Nigeria
, The National Agency for Food and Drug Administration and Control (PV/PMS Directorate) has received a notification of illegal distribution and sale of unregistered brands of Milky Creamer Products. The products are said to be widely distributed and sold across the ountry particularly in the northern part of Nigeria due to high demand for it. […]
